Tyna Moore, ND, DC is a leading expert in holistic regenerative medicine and metabolic resilience, with nearly three decades of experience in the regenerative medicine space
Retatrutide vs Tirzepatide Compared Retatrutide vs tirzepatide compared: 28.7% vs 22.5% weight loss, triple vs dual agonist mechanism, side effects, dosing, cost, and FDA status.
Retatrutide reduces thirst perception while GI symptoms can cause fluid loss
Tirzepatide (Mounjaro, Zepbound) operates through dual mechanisms, targeting both GLP-1 and GIP receptors for enhanced insulin and glucagon regulation
Invest in muscle preservation
Key differences between berberine and GLP-1 receptor agonists: Regulatory status GLP-1 agonists are MHRA-licensed prescription medicines with established efficacy and safety profiles